Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Kaoru Nishiyama"'
Autor:
Ryota Horibe, Motohiro Yokota, Koujiro Uemura, Midori Hashimoto, Naoki Kawagishi, Kaoru Nishiyama
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 12, p1797-1800, 4p
Autor:
Hiromitsu Domen, Yasuhiro Hida, Masaaki Sato, Haruka Takahashi, Tatsuru Ishikawa, Yosuke Shionoya, Midori Hashimoto, Kaoru Nishiyama, Yuma Aoki, Kazuho Inoko, Syotaro Furukawa, Kazuomi Ichinokawa, Hidehisa Yamada
Publikováno v:
Surgical Case Reports, Vol 4, Iss 1, Pp 1-6 (2018)
Abstract Background Thymic large cell neuroendocrine carcinoma (LCNEC) is extremely rare. The detailed clinical features of thymic LNCECs remain unknown. Case presentation A 90-year-old man with a history of diabetes mellitus, chronic renal failure,
Externí odkaz:
https://doaj.org/article/5bb65bb4ff10472a8da68a433909509c
Publikováno v:
Paediatrica Indonesiana, Vol 41, Iss 1, Pp 56-9 (2017)
The molecular and pedigree analyses in a Javanese Chinese family were carried oul on glucose-6-phosphate dehydrogenase deficiencies. By method of MPTP scanning without the sequencing steps, those variants could be confirmed. Two out of three sons wer
Externí odkaz:
https://doaj.org/article/d1b03bfaf40943459b398c9ba3b32cec
Autor:
Taku Hatakeyama, Tatsuru Ishikawa, Kaoru Nishiyama, Midori Hashimoto, Ryota Horibe, Takeyuki Sawai, Yasunari Takakuwa, Hiromitsu Domen, Masaaki Satoh
Publikováno v:
Internal Medicine. 61:401-405
A 78-year-old woman with multiple lung nodules, epithelial growth factor receptor (EGFR) exon 20 insertion mutations, and diagnosed with advanced lung adenocarcinoma (cT4N3M1a, stage IVA), was referred to our hospital. She received immune checkpoint
Publikováno v:
The American Journal of the Medical Sciences. 365:e91-e92
Autor:
Terufumi Kubo, Yosuke Shionoya, Kaoru Nishiyama, Midori Hashimoto, Haruka Takahashi, Yoshihiko Hirohashi, Tomohide Tsukahara, Toshihiko Torigoe, Yasunari Takakuwa, Munehide Nakatsugawa, Takayuki Kanaseki
Publikováno v:
Anticancer Research. 41:3699-3706
Background/aim Immune checkpoint inhibitors (ICIs), including nivolumab and pembrolizumab, have recently been shown to have clinical benefits in patients with advanced non-small cell lung cancer (NSCLC). The novel tumour responses to these agents are
Autor:
Joji Yoshikawa, Hisanao Takahashi, Yoshinobu Kawahara, Kaoru Nishiyama, Naoto Kinoshita, Naoya Takeishi
Publikováno v:
IEEJ Transactions on Electronics, Information and Systems. 141:712-719
Publikováno v:
The American journal of the medical sciences.
Publikováno v:
Case Reports in Oncology, Vol 4, Iss 1, Pp 198-203 (2011)
The coexistence of lung cancer and multiple myeloma (MM) is rare. A search of the English literature revealed only 5 case reports to date. We describe a case of MM that presented in a 78-year-old lung cancer patient after 20 months of treatment with
Externí odkaz:
https://doaj.org/article/ebb11f33895d4c67abce2ae9b9f65323
Autor:
Ryota Horibe, Taku Hatakeyama, Tatsuru Ishikawa, Takeyuki Sawai, Midori Hashimoto, Hiromitsu Domen, Yasunari Takakuwa, Masaaki Satoh, Kaoru Nishiyama
Publikováno v:
Internal Medicine; 2022, Vol. 61 Issue 3, p401-405, 5p